KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Precigen (PGEN) Cash & Equivalents: 2011-2024

Historic Cash & Equivalents for Precigen (PGEN) over the last 14 years, with Dec 2024 value amounting to $29.5 million.

  • Precigen's Cash & Equivalents fell 42.07% to $14.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $14.3 million, marking a year-over-year decrease of 42.07%. This contributed to the annual value of $29.5 million for FY2024, which is 289.51% up from last year.
  • Latest data reveals that Precigen reported Cash & Equivalents of $29.5 million as of FY2024, which was up 289.51% from $7.6 million recorded in FY2023.
  • Precigen's Cash & Equivalents' 5-year high stood at $51.8 million during FY2020, with a 5-year trough of $4.9 million in FY2022.
  • Over the past 3 years, Precigen's median Cash & Equivalents value was $7.6 million (recorded in 2023), while the average stood at $14.0 million.
  • As far as peak fluctuations go, Precigen's Cash & Equivalents tumbled by 86.66% in 2022, and later surged by 289.51% in 2024.
  • Yearly analysis of 5 years shows Precigen's Cash & Equivalents stood at $51.8 million in 2020, then decreased by 29.67% to $36.4 million in 2021, then crashed by 86.66% to $4.9 million in 2022, then spiked by 55.99% to $7.6 million in 2023, then spiked by 289.51% to $29.5 million in 2024.